Nyxoah S.A. (NYXH)

$9.6932

-0.31 (-3.07%)
Rating:
Recommendation:
-
Symbol NYXH
Price $9.6932
Beta 0.000
Volume Avg. 0.01M
Market Cap 257.316M
Shares () -
52 Week Range 7.46-34.2
1y Target Est -
DCF Unlevered NYXH DCF ->
DCF Levered NYXH LDCF ->
ROE -21.25% Sell
ROA -14.56% Sell
Operating Margin -
Debt / Equity 20.71% Neutral
P/E -
P/B 1.54 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NYXH news


Healthcare
Medical Instruments & Supplies
NASDAQ Global Market

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.